ArticleJournal of translational medicine2024

EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma.

Qian Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.